Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Get Rating) in a research report released on Thursday. The brokerage issued a buy rating on the stock.

Other analysts have also recently issued research reports about the stock. Sanford C. Bernstein initiated coverage on shares of Fresenius Medical Care AG & Co. KGaA in a research note on Tuesday, March 7th. They set a market perform rating for the company. HSBC cut shares of Fresenius Medical Care AG & Co. KGaA from a hold rating to a reduce rating in a research note on Tuesday, March 7th. Truist Financial upped their price objective on shares of Fresenius Medical Care AG & Co. KGaA from $17.00 to $22.00 and gave the company a hold rating in a research note on Thursday, February 23rd. Finally, Jefferies Financial Group cut shares of Fresenius Medical Care AG & Co. KGaA from a buy rating to an underperform rating and dropped their price objective for the company from $14.00 to $11.70 in a research note on Monday, January 2nd. Four analysts have rated the stock with a sell rating, six have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, Fresenius Medical Care AG & Co. KGaA currently has an average rating of Hold and an average target price of $28.20.

Fresenius Medical Care AG & Co. KGaA Stock Up 0.6 %

Shares of NYSE FMS opened at $19.44 on Thursday. Fresenius Medical Care AG & Co. KGaA has a 12-month low of $12.78 and a 12-month high of $34.65. The stock has a market cap of $11.41 billion, a PE ratio of 16.20 and a beta of 1.00. The company has a current ratio of 1.27, a quick ratio of 0.91 and a debt-to-equity ratio of 0.46. The company has a 50-day moving average of $19.06 and a 200 day moving average of $16.57.

Hedge Funds Weigh In On Fresenius Medical Care AG & Co. KGaA

Institutional investors and hedge funds have recently bought and sold shares of the company. Veriti Management LLC acquired a new position in shares of Fresenius Medical Care AG & Co. KGaA in the 3rd quarter worth approximately $251,000. Legacy Wealth Asset Management LLC lifted its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 18.3% in the 3rd quarter. Legacy Wealth Asset Management LLC now owns 63,714 shares of the company’s stock worth $895,000 after acquiring an additional 9,856 shares during the last quarter. Guardian Capital Advisors LP lifted its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 42.1% in the 3rd quarter. Guardian Capital Advisors LP now owns 81,420 shares of the company’s stock worth $1,045,000 after acquiring an additional 24,117 shares during the last quarter. Engineers Gate Manager LP acquired a new position in shares of Fresenius Medical Care AG & Co. KGaA in the 3rd quarter worth approximately $415,000. Finally, Greenleaf Trust acquired a new position in shares of Fresenius Medical Care AG & Co. KGaA in the 3rd quarter worth approximately $461,000. 5.56% of the stock is currently owned by institutional investors and hedge funds.

Fresenius Medical Care AG & Co. KGaA Company Profile

(Get Rating)

Fresenius Medical Care AG & Co KgaA provides products and services for individuals with renal diseases. The firm develops and manufactures health care products, which includes dialysis and non-dialysis products. It operates through the following segments: North America, EMEA, Asia-Pacific, and Latin America.